RAINBOW Study: RAnibizumab Compared With Laser Therapy for the Treatment of INfants BOrn Prematurely With Retinopathy of Prematurity
Clinical trial NCT02375971 · COMPLETED
Trial details
- NCT number
- NCT02375971
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2015-12-30
- Primary completion
- 2017-12-14
- Enrollment
- 224
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.